Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis
Clinical trial NCT05579730 · COMPLETED
Trial details
- NCT number
- NCT05579730
- Sponsor
- Bausch & Lomb Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-12
- Primary completion
- 2023-07-22
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.